Finding 1190947 (2025-002)

Material Weakness Repeat Finding
Requirement
N
Questioned Costs
-
Year
2025
Accepted
2026-03-27
Audit: 395231
Organization: Wake Forest University (NC)
Auditor: KPMG LLP

AI Summary

  • Core Issue: 22 out of 520 data elements tested were reported inaccurately, affecting student enrollment status, OPEID number, and program-level effective dates.
  • Impacted Requirements: Compliance with NSLDS reporting standards and internal controls under 34 CFR and 2 CFR was not met, risking data integrity.
  • Recommended Follow-Up: Enhance review controls for enrollment data accuracy and implement post-submission reconciliation procedures to prevent future discrepancies.

Finding Text

Finding 2025-002: NSLDS Reporting Federal Agency U.S. Department of Education Federal Program Student Financial Assistance Cluster (ALN # 84.268, 84.063) Federal Award Year July 1, 2024 through June 30, 2025 Federal Award Numbers P063P241963; P268K251963; P268K256998; P268K256953; P268K258670; P268K256952 Criteria or Requirement Per Sections 34 CFR 690.83(b)(2) and 34 CFR 685.309, a school shall update the student status confirmation report for changes in student status, report the date the enrollment status was effective and return the student status confirmation report to the Secretary within 30 days unless it plans to submit an enrollment report within the next 60 days of receipt. Per Sections 4.4.2 through 4.4.4 of the NSLDS enrollment reporting guide, institutions are responsible for accurately reporting all Campus-Level Record data elements and considers certain data elements to be high risk including OPEID Number, Enrollment Effective Date, Enrollment Status, and Certification Date. Per Section 4.4.8 of the NSLDS enrollment reporting guide, institutions are responsible for accurately reporting all Program-Level Record data elements and considers certain data elements to be high risk including OPEID Number, CIP Code, CIP Year, Credential Level, Published Program Length Measurement, Published Program Length, Program Begin Date, Program Enrollment Status, and Program Enrollment Effective Date. Per 2 CFR 200.303, the non-Federal entity must establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. Condition Found For 22 out of the 520 data elements tested across a sample of 40 students, the data element was not reported accurately. The data elements not reported accurately included the student's enrollment status, OPEID number, program-level effective date, and the published program length. There were no exceptions related to the timeliness of NSLDS reporting identified. • For 1 out of 40 students, the student’s status was inaccurately reported as Withdrawn while studying abroad rather than Full-time at both the Campus-Level Record and the Program-Level Record. • For 8 out of 40 students, the incorrect OPEID Number was reported. • For 2 out of 40 students who had a status change from Withdrawn to Full-time, the effective date of the status change was not reported accurately within the Program-Level Record. The effective date was reported as 7/5/2022 rather than 2/10/2025. • For 7 out of 40 students, the effective date for the Graduated status reported to NSLDS at the Program-Level Record did not match the Campus-Level Record by 1-9 days. • For 2 out of 40 students, the effective date for the Half-time status reported to NSLDS at the Program- Level Record did not match the Campus-Level Record by 23-49 days. • For 1 out of 40 students, the Published Program Length was reported at 1.5 years rather than 1.1 years. Possible Cause and Asserted Effect The control that management reviews all reports for the accuracy of all data elements prior to submission was not operating at a level to ensure that enrollment status, enrollment effective date, published program length, and OPEID number were accurately and consistently reported to NSLDS. Questioned Costs None identified. Sampling The sample was not intended to be, and was not, a statistically valid sample. Identification of Whether the Audit Finding is a Repeat of a Finding in the Immediately Prior Audit No. Recommendation We recommend the University enhance the precision of the control around the review of accuracy of the enrollment statuses, program level data records, and campus level data records within the NSLDS reporting submissions. Views of Responsible Officials The University agrees with the finding and recommendation to enhance the precision of the control around the review of accuracy of the enrollment statuses, program level data records, and campus level data records within the NSLDS reporting submissions. To further strengthen oversight and prevent recurrence, the Office of Student Financial Aid will implement documented post-submission reconciliation procedures following National Student Clearinghouse reporting cycles. These reviews will focus on high-risk enrollment reporting elements, including campus changes, program status changes, and other updates affecting NSLDS reporting, and will validate the accuracy of OPEID assignments and program-level effective dates against institutional records.

Corrective Action Plan

The University acknowledges the findings related to NSLDS enrollment reporting, including discrepancies involving OPEID reporting, program-level status effective dates, and other enrollment reporting data elements. The University agrees with the recommendation to enhance the precision of the control surrounding the review of enrollment status records, program-level data records, and campus-level data records included in NSLDS reporting submissions. Several corrective actions have already been implemented to address the identified exceptions. Updates have been made within the National Student Clearinghouse (NSC) reporting processes to ensure students are assigned to the appropriate branch codes and that campus-level records reflect the correct OPEID for each reporting entity. In addition, affected student records have been reviewed and updated to ensure program-level status records and effective dates are accurate within the NSC system. Going forward, the Registrar’s Office will monitor enrollment status changes and campus assignments within the NSC reporting process to ensure that status changes, program updates, and campus-level reporting elements are reflected accurately and transmitted in accordance with NSLDS reporting requirements. To further strengthen oversight and prevent recurrence, the Office of Student Financial Aid will implement documented post-submission reconciliation procedures following NSC reporting cycles. These reviews will focus on high-risk enrollment reporting elements, including campus changes, program status changes, and other updates affecting NSLDS reporting, and will validate the accuracy of OPEID assignments and program-level effective dates against institutional records. These enhancements are intended to improve the precision of the University’s existing controls and ensure the accuracy and completeness of future NSLDS enrollment reporting submissions.

Categories

Internal Control / Segregation of Duties Student Financial Aid Reporting Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 1190945 2025-002
    Material Weakness Repeat
  • 1190946 2025-002
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
84.268 FEDERAL DIRECT STUDENT LOANS $54.75M
93.RD Lung Organ Tissue Equivalent Platform For Modeling Chlorine Gas Toxicology: $6.82M
14.251 ECONOMIC DEVELOPMENT INITIATIVE, COMMUNITY PROJECT FUNDING, AND MISCELLANEOUS GRANTS $4.64M
84.063 FEDERAL PELL GRANT PROGRAM $4.14M
84.038 FEDERAL PERKINS LOAN PROGRAM_FEDERAL CAPITAL CONTRIBUTIONS $3.77M
93.493 CONGRESSIONAL DIRECTIVES $2.25M
93.917 HIV CARE FORMULA GRANTS $1.81M
93.RD Organ Tissue Equivalent (OTE) Platform for Vaccine Testing $1.55M
93.243 SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE $1.42M
20.614 NATIONAL HIGHWAY TRAFFIC SAFETY ADMINISTRATION (NHTSA) DISCRETIONARY SAFETY GRANTS AND COOPERATIVE AGREEMENTS $1.41M
93.RD Fibrosis 2.0 study $1.30M
98.001 USAID FOREIGN ASSISTANCE FOR PROGRAMS OVERSEAS $1.22M
12.RD CONSORT $959,487
93.958 BLOCK GRANTS FOR COMMUNITY MENTAL HEALTH SERVICES $883,861
93.RD Women Health Initiative - Regional Center $864,613
47.049 MATHEMATICAL AND PHYSICAL SCIENCES $760,402
12.630 BASIC, APPLIED, AND ADVANCED RESEARCH IN SCIENCE AND ENGINEERING $722,195
93.918 GRANTS TO PROVIDE OUTPATIENT EARLY INTERVENTION SERVICES WITH RESPECT TO HIV DISEASE $666,913
84.033 FEDERAL WORK-STUDY PROGRAM $659,521
84.007 FEDERAL SUPPLEMENTAL EDUCATIONAL OPPORTUNITY GRANTS $638,869
93.959 BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE $635,368
93.253 POISON CENTER SUPPORT AND ENHANCEMENT GRANT $622,526
16.001 LAW ENFORCEMENT ASSISTANCE NARCOTICS AND DANGEROUS DRUGS LABORATORY ANALYSIS $579,656
93.RD (VISION) Strategies for Whole Eye Transplant $521,310
27.011 INTERGOVERNMENTAL PERSONNEL ACT (IPA) MOBILITY PROGRAM $512,917
93.084 PREVENTION OF DISEASE, DISABILITY, AND DEATH BY INFECTIOUS DISEASES $505,849
93.RD Community-Based Capacity Restoration Planning $483,815
93.RD Survelliance of Acutely III Adults with Respiratory Virus Sars Cov 2 $467,933
12.RD Chilled Platelet Study $449,325
43.RD Space Operations $448,467
12.RD Assembly of Topologic $440,535
12.RD Development of Gel for Prevention of Combat-Related Infections $427,022
93.928 SPECIAL PROJECTS OF NATIONAL SIGNIFICANCE $410,876
93.RD ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) FIELD CENTER $410,408
12.RD Determining The Fundamental Differences Among Tissue Org $402,722
93.173 RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS $365,777
93.867 VISION RESEARCH $337,277
12.340 NAVAL MEDICAL RESEARCH AND DEVELOPMENT $336,991
93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS $333,883
81.049 OFFICE OF SCIENCE FINANCIAL ASSISTANCE PROGRAM $290,487
93.RD ELC Project K8 Threat of Antibiotic-Resistant Gonorrhea: $283,357
93.837 CARDIOVASCULAR DISEASES RESEARCH $282,872
93.RD Advanced Research and Development of Regulatory Science $281,605
93.879 MEDICAL LIBRARY ASSISTANCE $248,048
47.070 COMPUTER AND INFORMATION SCIENCE AND ENGINEERING $244,772
93.RD The Atherosclerosis Risk in Communities (ARIC) Study Field Center $241,048
21.027 CORONAVIRUS STATE AND LOCAL FISCAL RECOVERY FUNDS $239,484
93.113 ENVIRONMENTAL HEALTH $235,290
93.994 MATERNAL AND CHILD HEALTH SERVICES BLOCK GRANT TO THE STATES $219,362
12.RD Military-Civilian Prehospital Burn Provider Education Research Program $191,280
93.003 PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND $179,677
93.RD Development of a model to assess maternal antibody $177,608
12.351 SCIENTIFIC RESEARCH - COMBATING WEAPONS OF MASS DESTRUCTION $168,100
93.RD REBOA- Rahbar/Jordan TexasAM $166,533
16.575 CRIME VICTIM ASSISTANCE $162,446
93.RD Targeting ceramide metabolism in AML $154,449
93.RD Fungal Translocation in Chronic Obstructive Pulmonary Disease $150,785
93.121 ORAL DISEASES AND DISORDERS RESEARCH $145,671
12.RD Human Microengineered Organ Tissue Equivalents for Modeling the Effects of Chemical Agents $144,385
93.RD Multi-component CRC screening intervention effectiveness $141,933
93.RD Simult. mRNA COVID-19 & IIV4 Vaccine $134,994
47.076 STEM EDUCATION (FORMERLY EDUCATION AND HUMAN RESOURCES) $133,470
93.107 AREA HEALTH EDUCATION CENTERS $128,288
93.361 NURSING RESEARCH $126,398
93.069 PUBLIC HEALTH EMERGENCY PREPAREDNESS $123,730
93.286 DISCOVERY AND APPLIED RESEARCH FOR TECHNOLOGICAL INNOVATIONS TO IMPROVE HUMAN HEALTH $122,615
93.110 MATERNAL AND CHILD HEALTH FEDERAL CONSOLIDATED PROGRAMS $115,627
93.RD Multi-Ethnic Study of Atherosclerosis (MESA) $114,105
12.RD Partially Automated Critical Care Management PACCMAN Refinement $112,445
47.050 GEOSCIENCES $106,694
93.RD Training and Implementation Resources for the ChiCAS $97,498
12.431 BASIC SCIENTIFIC RESEARCH $92,891
66.475 GEOGRAPHIC PROGRAMS – GULF OF MEXICO PROGRAM $92,865
93.978 SEXUALLY TRANSMITTED DISEASES (STD) PROVIDER EDUCATION GRANTS $90,290
12.007 MILITARY HEALTH SERVICES RESEARCH (MHSR) $88,404
93.250 GERIATRIC ACADEMIC CAREER AWARDS DEPARTMENT OF HEALTH AND HUMAN SERVICES $86,562
93.RD Atherosclerosis Risk in Communities (ARIC) Study - Coordinating Center: $85,300
93.RD Jackson Heart Study $83,307
93.242 MENTAL HEALTH RESEARCH GRANTS $80,746
93.RD Heartshare Data - RTI International $74,742
93.RD REGARDS in-home visit $73,109
47.083 INTEGRATIVE ACTIVITIES $70,918
12.RD Advanced Ballistics Technology: Material Development, Characterization and Computational Modeling $69,109
93.136 INJURY PREVENTION AND CONTROL RESEARCH AND STATE AND COMMUNITY BASED PROGRAMS $68,113
93.RD Jackson Heart Surveillance Study (JHS Surveilliance): $63,885
93.839 BLOOD DISEASES AND RESOURCES RESEARCH $63,564
10.310 AGRICULTURE AND FOOD RESEARCH INITIATIVE (AFRI) $62,852
93.RD Modeling equity impact of age restrictedlocation policies $60,687
93.172 HUMAN GENOME RESEARCH $57,662
93.124 NURSE ANESTHETIST TRAINEESHIP $55,620
93.334 THE HEALTHY BRAIN INITIATIVE: TECHNICAL ASSISTANCE TO IMPLEMENT PUBLIC HEALTH ACTIONS RELATED TO COGNITIVE HEALTH, COGNITIVE IMPAIRMENT, AND CAREGIVING AT THE STATE AND LOCAL LEVELS $55,451
93.RD Shade_Duke_Main Preventable Study $54,129
93.583 REFUGEE AND ENTRANT ASSISTANCE WILSON/FISH PROGRAM $52,351
93.RD Harm Reduction Among Patients Experiencing Human Trafficking $50,000
93.310 TRANS-NIH RESEARCH SUPPORT $48,166
93.RD Subcontract for Strategies and Treatments for Respiratory and Viral Emergencies Study Payments (STRIVE) $47,870
84.336 TEACHER QUALITY PARTNERSHIP GRANTS $46,822
93.RD Tele-COPD $46,694
93.323 EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC) $46,142
93.211 TELEHEALTH PROGRAMS $44,613
93.RD PROMOTE $43,566
64.RD Structural & Functional Neurobiology of Veterans Grants: $43,044
43.003 EXPLORATION $41,971
93.397 CANCER CENTERS SUPPORT GRANTS $41,100
93.153 COORDINATED SERVICES AND ACCESS TO RESEARCH FOR WOMEN, INFANTS, CHILDREN, AND YOUTH $39,870
93.273 ALCOHOL RESEARCH PROGRAMS $38,475
47.074 BIOLOGICAL SCIENCES $37,890
93.889 NATIONAL BIOTERRORISM HOSPITAL PREPAREDNESS PROGRAM $36,854
10.331 GUS SCHUMACHER NUTRITION INCENTIVE PROGRAM $35,793
93.RD OPICO $35,055
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $30,830
93.351 RESEARCH INFRASTRUCTURE PROGRAMS $29,328
47.RD NASA Awards $29,184
93.396 CANCER BIOLOGY RESEARCH $28,655
93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH $27,392
93.865 CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH $26,725
93.840 TRANSLATION AND IMPLEMENTATION SCIENCE RESEARCH FOR HEART, LUNG, BLOOD DISEASES, AND SLEEP DISORDERS $25,074
47.075 SOCIAL, BEHAVIORAL, AND ECONOMIC SCIENCES $24,663
12.RD Driving Pressure-Limited Ventilation in Hpoxemic Respiratory Failure $24,315
93.RD Defining the role of mitochondrial injury in MEK inhibitor cardiotoxicity $23,466
93.073 BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES - PREVENTION AND SURVEILLANCE $22,434
45.149 PROMOTION OF THE HUMANITIES DIVISION OF PRESERVATION AND ACCESS $22,137
93.RD Soliman_Strong Heart Study $21,019
81.RD Assessing Environmental and Health Impacts $20,923
93.912 RURAL HEALTH CARE SERVICES OUTREACH, RURAL HEALTH NETWORK DEVELOPMENT AND SMALL HEALTH CARE PROVIDER QUALITY IMPROVEMENT $19,733
93.233 NATIONAL CENTER ON SLEEP DISORDERS RESEARCH $19,346
93.353 21ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT $19,311
93.433 ACL NATIONAL INSTITUTE ON DISABILITY, INDEPENDENT LIVING, AND REHABILITATION RESEARCH $18,675
93.945 ASSISTANCE PROGRAMS FOR CHRONIC DISEASE PREVENTION AND CONTROL $16,425
93.080 BLOOD DISORDER PROGRAM: PREVENTION, SURVEILLANCE, AND RESEARCH $16,406
93.RD HTN study $16,331
93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING $15,668
93.RD Substance misuse and pain management in the Lumbee Tribe $15,630
12.RD Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury $14,776
93.RD CHS Research for the Cardiovascular Health of Older Adul18295 $14,548
93.318 PROTECTING AND IMPROVING HEALTH GLOBALLY: BUILDING AND STRENGTHENING PUBLIC HEALTH IMPACT, SYSTEMS, CAPACITY AND SECURITY $13,666
93.RD Impact of Nicotine Reduction on Adolescent Cigarette Use: $13,640
12.RD Regenerative Rehabilitation for Complex Musculoskeletal Trauma $13,634
93.398 CANCER RESEARCH MANPOWER $13,152
47.041 ENGINEERING $12,780
93.262 OCCUPATIONAL SAFETY AND HEALTH PROGRAM $12,317
93.399 CANCER CONTROL $12,256
93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH $12,227
12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT $11,540
93.RD Combination Anti-amyloid Therapy for Preclinical Alzheim $10,656
10.216 1890 INSTITUTION CAPACITY BUILDING GRANTS $10,479
84.425 EDUCATION STABILIZATION FUND $10,102
93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH $10,065
93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS $10,053
93.307 MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH $10,048
93.989 INTERNATIONAL RESEARCH AND RESEARCH TRAINING $9,449
47.084 NSF TECHNOLOGY, INNOVATION, AND PARTNERSHIPS $8,723
93.RD MAIN-CAV-Randomized Trial of Maintainance Cabozantinib and Avelumab $8,429
93.RD Klepin and Southwest Oncology Group for CTSU S2114 $8,416
93.RD Phase III Trial of Stereotactic Radiosurgery (SRS) $8,148
94.013 AMERICORPS VOLUNTEERS IN SERVICE TO AMERICA 94.013 $8,128
93.393 CANCER CAUSE AND PREVENTION RESEARCH $7,814
93.RD Regulation and Function of Very Long Chain Fatty Acid Biosynthesis $7,465
93.924 RYAN WHITE HIV/AIDS DENTAL REIMBURSEMENT AND COMMUNITY BASED DENTAL PARTNERSHIP GRANTS $6,864
93.RD High Risk Prostate Cancer Evaluating $6,831
93.RD STEP $6,438
93.RD Exploration of bioactive components in Hawaiian mamaki tea $6,252
93.226 RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES $6,088
93.008 MEDICAL RESERVE CORPS SMALL GRANT PROGRAM $5,278
93.RD NCI MYELOMATCH CLINICAL TRIALS $5,245
93.350 NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES $5,177
93.421 STRENGTHENING PUBLIC HEALTH SYSTEMS AND SERVICES THROUGH NATIONAL PARTNERSHIPS TO IMPROVE AND PROTECT THE NATION’S HEALTH $5,147
84.220 CENTERS FOR INTERNATIONAL BUSINESS EDUCATION $4,515
12.800 AIR FORCE DEFENSE RESEARCH SCIENCES PROGRAM $4,235
12.RD ABRUPT2 $4,213
93.838 LUNG DISEASES RESEARCH $4,025
93.RD NRG BN012 $4,025
93.RD Jagosky Megan NCI $3,908
45.312 NATIONAL LEADERSHIP GRANTS $3,862
93.RD Massive Transfusion in Children II MATIC 2 $3,687
93.103 FOOD AND DRUG ADMINISTRATION RESEARCH $3,482
43.001 SCIENCE $3,273
93.RD Cancer Research $3,075
93.RD Primary Lung Tumor Stereotactic Body Radiation Therapy $3,004
12.RD Novel Topical Antibiotic Therapy $2,632
93.395 CANCER TREATMENT RESEARCH $2,620
93.RD Optimal Perioperative Therapy For Incidental Gallbladder $2,445
93.RD Venetoclax and HMA-Based Therapies for Leukemia $2,064
93.RD A Randomized Phase II/III Study of Conventional $2,014
93.RD Randomized Phase III Trial of Bortezomib Lenalidomide a $1,946
93.RD Randomized Phase III Study of Ibrutinib (PCI-32765)-based Therapy: $1,902
84.379 TEACHER EDUCATION ASSISTANCE FOR COLLEGE AND HIGHER EDUCATION GRANTS (TEACH GRANTS) $1,886
93.127 EMERGENCY MEDICAL SERVICES FOR CHILDREN $1,858
93.RD Evaluating Fitness-for-Use of Electronic Health Records $1,418
43.007 SPACE OPERATIONS $1,410
93.RD Change in Relative Cerebral Blood Volume as a Biomarker: $1,250
93.RD Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs $1,012
93.RD A Randomized Phase II/III Trial of Modern Immunotherapy $996
93.RD Phase II Study of DaratumumabHyaluronidase $968
93.RD Strata STEPs $858
12.300 BASIC AND APPLIED SCIENTIFIC RESEARCH $775
93.RD Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT $509
93.RD STEP - Master Protocol $457
93.RD Phase II Study of Venetoclax Plus Chemotherapy forLeukemia: A Tier 1 MYELOMATCH Clinical Trial $258
93.RD Phase III Trial of Perioperative Immunotherapy for Stage III IV Cutaneous Squamous Cell Carcinoma $79
45.310 GRANTS TO STATES $-19
12.RD National Clinical Trials Network $-50
93.969 PPHF GERIATRIC EDUCATION CENTERS $-149
93.077 FAMILY SMOKING PREVENTION AND TOBACCO CONTROL ACT REGULATORY RESEARCH $-3,581
93.213 RESEARCH AND TRAINING IN COMPLEMENTARY AND INTEGRATIVE HEALTH $-11,032
93.866 AGING RESEARCH $-13,620